HDACs class II-selective inhibition alters nuclear receptor-dependent differentiation.
Nebbioso A, Dell'Aversana C, Bugge A, Sarno R, Valente S, Rotili D, Manzo F, Teti D, Mandrup S, Ciana P, Maggi A, Mai A, Gronemeyer H, Altucci L.
Nebbioso A, et al. Among authors: valente s.
J Mol Endocrinol. 2010 Oct;45(4):219-28. doi: 10.1677/JME-10-0043. Epub 2010 Jul 16.
J Mol Endocrinol. 2010.
PMID: 20639404
Free article.